Join to view full profile
2800 Veterans Memorial Blvd Ste 140Metairie, LA 70002
Phone+1 225-767-0847
Fax+1 225-215-1380
Dr. Delacroix is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2009 - 2012
Ochsner Clinic FoundationResidency, Urology, 2005 - 2009
Louisiana State University School of MedicineInternship, Transitional Year, 2004 - 2005- Louisiana State University School of Medicine in New OrleansClass of 2004
Certifications & Licensure
LA State Medical License 2006 - 2027
MS State Medical License 2024 - 2027
TX State Medical License 2009 - 2027
AL State Medical License 2024 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013, 2015-2017
Clinical Trials
- Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Dec 10
- A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial Start of enrollment: 2021 Mar 17
- A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery Start of enrollment: 2019 Apr 15
Publications & Presentations
PubMed
- A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Can...Brian F Chapin, Marc Smaldone, Amado J Zurita, Jennifer Wang, Matthew R Cooperberg
European Urology. 2026-08-01 - Compliance With Intravesical Bacillus Calmette-Guérin Therapy for Nonmuscle-Invasive Bladder Cancer.Timothy F Carroll, Joseph P Bardot, Justin David, Marc Zucker, Ross E Straughan
Urology Practice. 2026-05-01 - Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.Heather H Cheng, Sam Callis, Evan Y Yu, Scott E Delacroix, Alexandra O Sokolova
European Urology Focus. 2026-01-01
Press Mentions
NRG Oncology Opens New “ARCHER” Clinical Trial (NRG-GU015) Testing a Shorter Treatment Duration of Radiation Therapy for Muscle Invasive Bladder CancerAugust 14th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
